The Centers for Medicare & Medicaid Services Friday finalized policy and technical changes to the Medicare Advantage and prescription drug benefit for contract year 2023. To improve MA plan oversight, the final rule would reinstate plan reporting on medical loss ratio requirements that were relaxed in 2017; require plans to demonstrate a sufficient provider network when applying for a new or expanded contract; strengthen CMS’s ability to evaluate plan performance when reviewing proposals for new or expanded contracts; require plans to provide certain materials to beneficiaries in culturally and linguistically appropriate ways; and strengthen oversight of third-party marketing organizations, among other consumer protection provisions. The rule also codifies provisions intended to improve and better assess quality for special needs plans that serve beneficiaries dually eligible for Medicare and Medicaid. 

Related News Articles

Headline
AHA yesterday submitted comments to the Centers for Medicare & Medicaid Services in response to a request for information on the Medicare Advantage program…
Headline
The Centers for Medicare & Medicaid Services today released a Request for Information seeking public comment to inform potential future rulemaking on…
Headline
The House Ways and Means Committee today voted to advance to the full House the Improving Seniors’ Timely Access to Care Act (H.R. 8487), AHA-supported…
Headline
In a letter submitted to the House Energy and Commerce Oversight and Investigations Subcommittee for a hearing today, AHA called for greater congressional…
Blog
After two years on the front lines in the battle against this pandemic, hospitals and health systems have seen a dramatic rise in costs of labor, drugs,…
Headline
The AHA today urged the Centers for Medicare & Medicaid Services to “take swift action to hold Medicare Advantage plans accountable for inappropriately and…